Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C15H28O2 |
Molecular Weight | 240.3816 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12C[C@@H](CC[C@@]1(C)CCC[C@@]2(C)O)C(C)(C)O
InChI
InChIKey=LKKDASYGWYYFIK-QHSBEEBCSA-N
InChI=1S/C15H28O2/c1-13(2,16)11-6-9-14(3)7-5-8-15(4,17)12(14)10-11/h11-12,16-17H,5-10H2,1-4H3/t11-,12-,14-,15-/m1/s1
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/21238547
Sources: https://www.ncbi.nlm.nih.gov/pubmed/21238547
Proximadiol was isolated from the rhizomes of Zingiber mekongense and leaves of Blumea balsamifera. Compound lacks ativiral and antibacterial activity. Proximadiol was found to inhibit platelet-activating factor receptor binding on platelets at micromolar concentrations.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL250 Sources: https://www.ncbi.nlm.nih.gov/pubmed/22002630 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/22002630
The reaction mixture consisted of 200 mL of washed rabbit platelet suspension, 25 mL of 3H-PAF (2.0 nM) with or without unlabelled
PAF (2.0 mM) and 15 mL of sample or control solution. The final concentrations of sample in the reaction mixtures were 18.2, 9.1, 4.5, 1.8 and 0.9 mg/mL. The reaction mixture was incubated at room temperature for 1 h. The free and bound ligands were separated by filtration technique using Whatman GF/C glass fibre filters. The final concentration of DMSO (control) in the reaction mixture was fixed at 0.1% to avoid interference with the receptor binding studies. The reaction mixture with 0.1% DMSO in saline was used as a control and cedrol was used as a positive control. The radioactivity was measured by scintillation counting. The difference between total radioactivities of bound 3H-PAF in the absence and presence of excess unlabelled PAF is defined as specific binding of the radiolabelled ligand.
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
165258
Created by
admin on Sat Dec 16 09:13:38 GMT 2023 , Edited by admin on Sat Dec 16 09:13:38 GMT 2023
|
PRIMARY | |||
|
DTXSID001317282
Created by
admin on Sat Dec 16 09:13:38 GMT 2023 , Edited by admin on Sat Dec 16 09:13:38 GMT 2023
|
PRIMARY | |||
|
4666-84-6
Created by
admin on Sat Dec 16 09:13:38 GMT 2023 , Edited by admin on Sat Dec 16 09:13:38 GMT 2023
|
PRIMARY | |||
|
Y2KBV9FZ9M
Created by
admin on Sat Dec 16 09:13:38 GMT 2023 , Edited by admin on Sat Dec 16 09:13:38 GMT 2023
|
PRIMARY | |||
|
2562551
Created by
admin on Sat Dec 16 09:13:38 GMT 2023 , Edited by admin on Sat Dec 16 09:13:38 GMT 2023
|
PRIMARY | |||
|
SUB69958
Created by
admin on Sat Dec 16 09:13:38 GMT 2023 , Edited by admin on Sat Dec 16 09:13:38 GMT 2023
|
PRIMARY | |||
|
Y2KBV9FZ9M
Created by
admin on Sat Dec 16 09:13:38 GMT 2023 , Edited by admin on Sat Dec 16 09:13:38 GMT 2023
|
PRIMARY | |||
|
100000135241
Created by
admin on Sat Dec 16 09:13:38 GMT 2023 , Edited by admin on Sat Dec 16 09:13:38 GMT 2023
|
PRIMARY |
ACTIVE MOIETY